Amarin Corporation (AMRN) gains on patent news
Amarin Corporation plc (NASDAQ: AMRN) added 1.9% to $7.11 after the company announced patent allowance related to combination product of Vascepa and Statin therapy. Share volume was 126,000, compared to an all-day average of 788,000
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here